Loading…

Synthesis and structure-activity relationships of 2-aryl-4-oxazolylmethoxy benzylglycines and 2-aryl-4-thiazolylmethoxy benzylglycines as novel, potent PPARalpha selective activators- PPARalpha and PPARgamma selectivity modulation

The synthesis and follow-up SAR studies of our development candidate 1 by incorporating 2-aryl-4-oxazolylmethoxy and 2-aryl-4-thiazolylmethoxy moieties into the oxybenzylglycine framework of the PPARalpha/gamma dual agonist muraglitazar is described. SAR studies indicate that different substituents...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry letters 2010-05, Vol.20 (9), p.2933-2937
Main Authors: Ye, Xiang-Yang, Chen, Stephanie, Zhang, Hao, Locke, Kenneth T, O'Malley, Kevin, Zhang, Litao, Srivastava, Raijit, Miao, Bowman, Meyers, Daniel, Monshizadegan, Hossain, Search, Debra, Grimm, Denise, Zhang, Rongan, Lippy, Jonathan, Twamley, Celeste, Muckelbauer, Jodi K, Chang, Chiehying, An, Yongmi, Hosagrahara, Vinayak, Zhang, Lisa, Yang, T-J, Mukherjee, Ranjan, Cheng, Peter T W, Tino, Joseph A
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 2937
container_issue 9
container_start_page 2933
container_title Bioorganic & medicinal chemistry letters
container_volume 20
creator Ye, Xiang-Yang
Chen, Stephanie
Zhang, Hao
Locke, Kenneth T
O'Malley, Kevin
Zhang, Litao
Srivastava, Raijit
Miao, Bowman
Meyers, Daniel
Monshizadegan, Hossain
Search, Debra
Grimm, Denise
Zhang, Rongan
Lippy, Jonathan
Twamley, Celeste
Muckelbauer, Jodi K
Chang, Chiehying
An, Yongmi
Hosagrahara, Vinayak
Zhang, Lisa
Yang, T-J
Mukherjee, Ranjan
Cheng, Peter T W
Tino, Joseph A
description The synthesis and follow-up SAR studies of our development candidate 1 by incorporating 2-aryl-4-oxazolylmethoxy and 2-aryl-4-thiazolylmethoxy moieties into the oxybenzylglycine framework of the PPARalpha/gamma dual agonist muraglitazar is described. SAR studies indicate that different substituents on the aryloxazole/thiazole moieties as well as the choice of carbamate substituent on the glycine moiety can significantly modulate the selectivity of PPARalpha versus PPARgamma. Potent, highly selective PPARalpha activators 2a and 2l, as well as PPARalpha activators with significant PPARgamma activity, such as 2s, were identified. The in vivo pharmacology of these compounds in preclinical animal models as well as their ADME profiles are discussed.
doi_str_mv 10.1016/j.bmcl.2010.03.019
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_733897261</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733897261</sourcerecordid><originalsourceid>FETCH-LOGICAL-p556-4999a03c378b936d0153db254f8f367101b9a403816215fa4d881972ac0ad55d3</originalsourceid><addsrcrecordid>eNp9kctOwzAQRS0kREvhB1gg79jgYsePJMuq4iVVooLuKydxGldOHGKnavrBfAcpLY8Vq9HMHN25ugPAFcFjgom4W4-TMjXjAPcDTMeYxCdgSJhgiDLMB-DcuTXGhGHGzsAgwJSLkIoh-HjrKl8opx2UVQadb9rUt41CMvV6o30HG2Wk17Zyha4dtDkMkGw6gxiyW7mzpjOl8oXddjBR1a4zK9OlulIHvR_WF_p_2MHKbpS5hbX1qvJwPp-8SlMXEjpl1N6Mgl-epLeNQ3_2-zv7biXL8pfeWy9t1h7MX4DTXBqnLo91BBYP94vpE5q9PD5PJzNUcy4Qi-NYYprSMEpiKjJMOM2SgLM8yqkI-6CTWDJMIyICwnPJsigicRjIFMuM84yOwM1Btm7se6ucX5bapcoYWSnbumVIadTzgvTk9ZFsk1Jly7rRZR_V8vsz9BODEZXY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733897261</pqid></control><display><type>article</type><title>Synthesis and structure-activity relationships of 2-aryl-4-oxazolylmethoxy benzylglycines and 2-aryl-4-thiazolylmethoxy benzylglycines as novel, potent PPARalpha selective activators- PPARalpha and PPARgamma selectivity modulation</title><source>Elsevier</source><creator>Ye, Xiang-Yang ; Chen, Stephanie ; Zhang, Hao ; Locke, Kenneth T ; O'Malley, Kevin ; Zhang, Litao ; Srivastava, Raijit ; Miao, Bowman ; Meyers, Daniel ; Monshizadegan, Hossain ; Search, Debra ; Grimm, Denise ; Zhang, Rongan ; Lippy, Jonathan ; Twamley, Celeste ; Muckelbauer, Jodi K ; Chang, Chiehying ; An, Yongmi ; Hosagrahara, Vinayak ; Zhang, Lisa ; Yang, T-J ; Mukherjee, Ranjan ; Cheng, Peter T W ; Tino, Joseph A</creator><creatorcontrib>Ye, Xiang-Yang ; Chen, Stephanie ; Zhang, Hao ; Locke, Kenneth T ; O'Malley, Kevin ; Zhang, Litao ; Srivastava, Raijit ; Miao, Bowman ; Meyers, Daniel ; Monshizadegan, Hossain ; Search, Debra ; Grimm, Denise ; Zhang, Rongan ; Lippy, Jonathan ; Twamley, Celeste ; Muckelbauer, Jodi K ; Chang, Chiehying ; An, Yongmi ; Hosagrahara, Vinayak ; Zhang, Lisa ; Yang, T-J ; Mukherjee, Ranjan ; Cheng, Peter T W ; Tino, Joseph A</creatorcontrib><description>The synthesis and follow-up SAR studies of our development candidate 1 by incorporating 2-aryl-4-oxazolylmethoxy and 2-aryl-4-thiazolylmethoxy moieties into the oxybenzylglycine framework of the PPARalpha/gamma dual agonist muraglitazar is described. SAR studies indicate that different substituents on the aryloxazole/thiazole moieties as well as the choice of carbamate substituent on the glycine moiety can significantly modulate the selectivity of PPARalpha versus PPARgamma. Potent, highly selective PPARalpha activators 2a and 2l, as well as PPARalpha activators with significant PPARgamma activity, such as 2s, were identified. The in vivo pharmacology of these compounds in preclinical animal models as well as their ADME profiles are discussed.</description><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2010.03.019</identifier><identifier>PMID: 20356736</identifier><language>eng</language><publisher>England</publisher><subject>Animals ; Anti-Inflammatory Agents - chemical synthesis ; Anti-Inflammatory Agents - chemistry ; Anti-Inflammatory Agents - pharmacokinetics ; Binding Sites ; Cricetinae ; Crystallography, X-Ray ; Glycine - analogs &amp; derivatives ; Glycine - chemical synthesis ; Glycine - pharmacokinetics ; Humans ; Male ; PPAR alpha - agonists ; PPAR alpha - metabolism ; PPAR gamma - agonists ; PPAR gamma - metabolism ; Rats ; Rats, Sprague-Dawley ; Structure-Activity Relationship</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 2010-05, Vol.20 (9), p.2933-2937</ispartof><rights>2010 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20356736$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ye, Xiang-Yang</creatorcontrib><creatorcontrib>Chen, Stephanie</creatorcontrib><creatorcontrib>Zhang, Hao</creatorcontrib><creatorcontrib>Locke, Kenneth T</creatorcontrib><creatorcontrib>O'Malley, Kevin</creatorcontrib><creatorcontrib>Zhang, Litao</creatorcontrib><creatorcontrib>Srivastava, Raijit</creatorcontrib><creatorcontrib>Miao, Bowman</creatorcontrib><creatorcontrib>Meyers, Daniel</creatorcontrib><creatorcontrib>Monshizadegan, Hossain</creatorcontrib><creatorcontrib>Search, Debra</creatorcontrib><creatorcontrib>Grimm, Denise</creatorcontrib><creatorcontrib>Zhang, Rongan</creatorcontrib><creatorcontrib>Lippy, Jonathan</creatorcontrib><creatorcontrib>Twamley, Celeste</creatorcontrib><creatorcontrib>Muckelbauer, Jodi K</creatorcontrib><creatorcontrib>Chang, Chiehying</creatorcontrib><creatorcontrib>An, Yongmi</creatorcontrib><creatorcontrib>Hosagrahara, Vinayak</creatorcontrib><creatorcontrib>Zhang, Lisa</creatorcontrib><creatorcontrib>Yang, T-J</creatorcontrib><creatorcontrib>Mukherjee, Ranjan</creatorcontrib><creatorcontrib>Cheng, Peter T W</creatorcontrib><creatorcontrib>Tino, Joseph A</creatorcontrib><title>Synthesis and structure-activity relationships of 2-aryl-4-oxazolylmethoxy benzylglycines and 2-aryl-4-thiazolylmethoxy benzylglycines as novel, potent PPARalpha selective activators- PPARalpha and PPARgamma selectivity modulation</title><title>Bioorganic &amp; medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>The synthesis and follow-up SAR studies of our development candidate 1 by incorporating 2-aryl-4-oxazolylmethoxy and 2-aryl-4-thiazolylmethoxy moieties into the oxybenzylglycine framework of the PPARalpha/gamma dual agonist muraglitazar is described. SAR studies indicate that different substituents on the aryloxazole/thiazole moieties as well as the choice of carbamate substituent on the glycine moiety can significantly modulate the selectivity of PPARalpha versus PPARgamma. Potent, highly selective PPARalpha activators 2a and 2l, as well as PPARalpha activators with significant PPARgamma activity, such as 2s, were identified. The in vivo pharmacology of these compounds in preclinical animal models as well as their ADME profiles are discussed.</description><subject>Animals</subject><subject>Anti-Inflammatory Agents - chemical synthesis</subject><subject>Anti-Inflammatory Agents - chemistry</subject><subject>Anti-Inflammatory Agents - pharmacokinetics</subject><subject>Binding Sites</subject><subject>Cricetinae</subject><subject>Crystallography, X-Ray</subject><subject>Glycine - analogs &amp; derivatives</subject><subject>Glycine - chemical synthesis</subject><subject>Glycine - pharmacokinetics</subject><subject>Humans</subject><subject>Male</subject><subject>PPAR alpha - agonists</subject><subject>PPAR alpha - metabolism</subject><subject>PPAR gamma - agonists</subject><subject>PPAR gamma - metabolism</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Structure-Activity Relationship</subject><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNp9kctOwzAQRS0kREvhB1gg79jgYsePJMuq4iVVooLuKydxGldOHGKnavrBfAcpLY8Vq9HMHN25ugPAFcFjgom4W4-TMjXjAPcDTMeYxCdgSJhgiDLMB-DcuTXGhGHGzsAgwJSLkIoh-HjrKl8opx2UVQadb9rUt41CMvV6o30HG2Wk17Zyha4dtDkMkGw6gxiyW7mzpjOl8oXddjBR1a4zK9OlulIHvR_WF_p_2MHKbpS5hbX1qvJwPp-8SlMXEjpl1N6Mgl-epLeNQ3_2-zv7biXL8pfeWy9t1h7MX4DTXBqnLo91BBYP94vpE5q9PD5PJzNUcy4Qi-NYYprSMEpiKjJMOM2SgLM8yqkI-6CTWDJMIyICwnPJsigicRjIFMuM84yOwM1Btm7se6ucX5bapcoYWSnbumVIadTzgvTk9ZFsk1Jly7rRZR_V8vsz9BODEZXY</recordid><startdate>20100501</startdate><enddate>20100501</enddate><creator>Ye, Xiang-Yang</creator><creator>Chen, Stephanie</creator><creator>Zhang, Hao</creator><creator>Locke, Kenneth T</creator><creator>O'Malley, Kevin</creator><creator>Zhang, Litao</creator><creator>Srivastava, Raijit</creator><creator>Miao, Bowman</creator><creator>Meyers, Daniel</creator><creator>Monshizadegan, Hossain</creator><creator>Search, Debra</creator><creator>Grimm, Denise</creator><creator>Zhang, Rongan</creator><creator>Lippy, Jonathan</creator><creator>Twamley, Celeste</creator><creator>Muckelbauer, Jodi K</creator><creator>Chang, Chiehying</creator><creator>An, Yongmi</creator><creator>Hosagrahara, Vinayak</creator><creator>Zhang, Lisa</creator><creator>Yang, T-J</creator><creator>Mukherjee, Ranjan</creator><creator>Cheng, Peter T W</creator><creator>Tino, Joseph A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20100501</creationdate><title>Synthesis and structure-activity relationships of 2-aryl-4-oxazolylmethoxy benzylglycines and 2-aryl-4-thiazolylmethoxy benzylglycines as novel, potent PPARalpha selective activators- PPARalpha and PPARgamma selectivity modulation</title><author>Ye, Xiang-Yang ; Chen, Stephanie ; Zhang, Hao ; Locke, Kenneth T ; O'Malley, Kevin ; Zhang, Litao ; Srivastava, Raijit ; Miao, Bowman ; Meyers, Daniel ; Monshizadegan, Hossain ; Search, Debra ; Grimm, Denise ; Zhang, Rongan ; Lippy, Jonathan ; Twamley, Celeste ; Muckelbauer, Jodi K ; Chang, Chiehying ; An, Yongmi ; Hosagrahara, Vinayak ; Zhang, Lisa ; Yang, T-J ; Mukherjee, Ranjan ; Cheng, Peter T W ; Tino, Joseph A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p556-4999a03c378b936d0153db254f8f367101b9a403816215fa4d881972ac0ad55d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Animals</topic><topic>Anti-Inflammatory Agents - chemical synthesis</topic><topic>Anti-Inflammatory Agents - chemistry</topic><topic>Anti-Inflammatory Agents - pharmacokinetics</topic><topic>Binding Sites</topic><topic>Cricetinae</topic><topic>Crystallography, X-Ray</topic><topic>Glycine - analogs &amp; derivatives</topic><topic>Glycine - chemical synthesis</topic><topic>Glycine - pharmacokinetics</topic><topic>Humans</topic><topic>Male</topic><topic>PPAR alpha - agonists</topic><topic>PPAR alpha - metabolism</topic><topic>PPAR gamma - agonists</topic><topic>PPAR gamma - metabolism</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ye, Xiang-Yang</creatorcontrib><creatorcontrib>Chen, Stephanie</creatorcontrib><creatorcontrib>Zhang, Hao</creatorcontrib><creatorcontrib>Locke, Kenneth T</creatorcontrib><creatorcontrib>O'Malley, Kevin</creatorcontrib><creatorcontrib>Zhang, Litao</creatorcontrib><creatorcontrib>Srivastava, Raijit</creatorcontrib><creatorcontrib>Miao, Bowman</creatorcontrib><creatorcontrib>Meyers, Daniel</creatorcontrib><creatorcontrib>Monshizadegan, Hossain</creatorcontrib><creatorcontrib>Search, Debra</creatorcontrib><creatorcontrib>Grimm, Denise</creatorcontrib><creatorcontrib>Zhang, Rongan</creatorcontrib><creatorcontrib>Lippy, Jonathan</creatorcontrib><creatorcontrib>Twamley, Celeste</creatorcontrib><creatorcontrib>Muckelbauer, Jodi K</creatorcontrib><creatorcontrib>Chang, Chiehying</creatorcontrib><creatorcontrib>An, Yongmi</creatorcontrib><creatorcontrib>Hosagrahara, Vinayak</creatorcontrib><creatorcontrib>Zhang, Lisa</creatorcontrib><creatorcontrib>Yang, T-J</creatorcontrib><creatorcontrib>Mukherjee, Ranjan</creatorcontrib><creatorcontrib>Cheng, Peter T W</creatorcontrib><creatorcontrib>Tino, Joseph A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ye, Xiang-Yang</au><au>Chen, Stephanie</au><au>Zhang, Hao</au><au>Locke, Kenneth T</au><au>O'Malley, Kevin</au><au>Zhang, Litao</au><au>Srivastava, Raijit</au><au>Miao, Bowman</au><au>Meyers, Daniel</au><au>Monshizadegan, Hossain</au><au>Search, Debra</au><au>Grimm, Denise</au><au>Zhang, Rongan</au><au>Lippy, Jonathan</au><au>Twamley, Celeste</au><au>Muckelbauer, Jodi K</au><au>Chang, Chiehying</au><au>An, Yongmi</au><au>Hosagrahara, Vinayak</au><au>Zhang, Lisa</au><au>Yang, T-J</au><au>Mukherjee, Ranjan</au><au>Cheng, Peter T W</au><au>Tino, Joseph A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and structure-activity relationships of 2-aryl-4-oxazolylmethoxy benzylglycines and 2-aryl-4-thiazolylmethoxy benzylglycines as novel, potent PPARalpha selective activators- PPARalpha and PPARgamma selectivity modulation</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2010-05-01</date><risdate>2010</risdate><volume>20</volume><issue>9</issue><spage>2933</spage><epage>2937</epage><pages>2933-2937</pages><eissn>1464-3405</eissn><abstract>The synthesis and follow-up SAR studies of our development candidate 1 by incorporating 2-aryl-4-oxazolylmethoxy and 2-aryl-4-thiazolylmethoxy moieties into the oxybenzylglycine framework of the PPARalpha/gamma dual agonist muraglitazar is described. SAR studies indicate that different substituents on the aryloxazole/thiazole moieties as well as the choice of carbamate substituent on the glycine moiety can significantly modulate the selectivity of PPARalpha versus PPARgamma. Potent, highly selective PPARalpha activators 2a and 2l, as well as PPARalpha activators with significant PPARgamma activity, such as 2s, were identified. The in vivo pharmacology of these compounds in preclinical animal models as well as their ADME profiles are discussed.</abstract><cop>England</cop><pmid>20356736</pmid><doi>10.1016/j.bmcl.2010.03.019</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier EISSN: 1464-3405
ispartof Bioorganic & medicinal chemistry letters, 2010-05, Vol.20 (9), p.2933-2937
issn 1464-3405
language eng
recordid cdi_proquest_miscellaneous_733897261
source Elsevier
subjects Animals
Anti-Inflammatory Agents - chemical synthesis
Anti-Inflammatory Agents - chemistry
Anti-Inflammatory Agents - pharmacokinetics
Binding Sites
Cricetinae
Crystallography, X-Ray
Glycine - analogs & derivatives
Glycine - chemical synthesis
Glycine - pharmacokinetics
Humans
Male
PPAR alpha - agonists
PPAR alpha - metabolism
PPAR gamma - agonists
PPAR gamma - metabolism
Rats
Rats, Sprague-Dawley
Structure-Activity Relationship
title Synthesis and structure-activity relationships of 2-aryl-4-oxazolylmethoxy benzylglycines and 2-aryl-4-thiazolylmethoxy benzylglycines as novel, potent PPARalpha selective activators- PPARalpha and PPARgamma selectivity modulation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T10%3A33%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20structure-activity%20relationships%20of%202-aryl-4-oxazolylmethoxy%20benzylglycines%20and%202-aryl-4-thiazolylmethoxy%20benzylglycines%20as%20novel,%20potent%20PPARalpha%20selective%20activators-%20PPARalpha%20and%20PPARgamma%20selectivity%20modulation&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Ye,%20Xiang-Yang&rft.date=2010-05-01&rft.volume=20&rft.issue=9&rft.spage=2933&rft.epage=2937&rft.pages=2933-2937&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2010.03.019&rft_dat=%3Cproquest_pubme%3E733897261%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p556-4999a03c378b936d0153db254f8f367101b9a403816215fa4d881972ac0ad55d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=733897261&rft_id=info:pmid/20356736&rfr_iscdi=true